Andal, Akila S.
HRN: 22-23-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
AMPICILLIN 250MG (VIAL)
11/21/2022
11/28/2022
IVT
220 Mg
6 Hrs
AGE W/ Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes